The fusion glycoprotein of the Edinburgh strain of respiratory syncytial (RS) virus was cloned from infected cell mRNA. A full-length clone was subjected to sequence analysis, and compared with other strains of RS virus. The inferred primary amino acid sequence was used to generate a nested set of overlapping peptides spanning the mature protein. Peptides were synthesized on polyethylene pins and examined for their reactivity towards high titre human antisera.
Introduction
Respiratory syncytial (RS) virus infects primarily the upper respiratory tract. However during the initial attack which usually occurs during the first year of life RS virus spreads to infect the lungs in 40~ of infants (Parrott et al., 1973) . Such life-threatening infections occur in the presence of significant levels of circulating maternal antibodies, reactive to most components of the RS virus (Ward et al., 1983) . Another important characteristic of RS virus is the ability to cause repeated episodes of infection in all age groups. There are no data to suggest that major antigenic variations account for this failure of multiple RS virus infections to induce longterm protective immunity. Although two subgroups of RS virus, termed A and B, have been recognized (Mufson et al., 1985) , neutralizing antibodies to the fusion glycoprotein (F) are cross-reactive whereas antibodies to the G glycoprotein are subgroup-specific (Walsh et al., 1987) .
Studies on experimentally infected mice (Taylor et al., 1984) and cotton rats (Walsh et al., 1984) showed that passive immunization with neutralizing monoclonal antibodies (MAbs) to either the F or G glycoproteins protected against lung infection and, to a lesser extent, against upper respiratory tract infection. These experimental findings are compatible with the fact that lifethreatening lung infections are rare or delayed in those babies with the highest cord blood titres of neutralizing antibodies to RS virus (Glezen et al., 1981) . The natural history of RS virus infection might be understood if the 0000-9117 © 1990 SGM neutralizing response to F is generally poor, short-lived or if minor strain variations in the F protein structure are common and induce resistance to neutralization. There is some evidence to suggest that a major neutralizing epitope on F is composed of a continuous sequence of amino acids (Trudel et al., 1987) . To assess whether human sera with high titres of neutralizing bodies are reactive at or near this site, we have prepared overlapping peptides representing parts of an F protein sequenced in this laboratory. Our sequence is compared to published data, looking for changes in amino acid composition.
Methods
Cells and virus. The Edinburgh strain of RS virus (Ogilvie et al., 1981) was grown in HEp-2 cells maintained in Dulbecco's MEM supplemented with 1 ~ (v/v) foetal calf serum (Ward et al., 1984) .
Isolation ofmRNA. RS virus-infected HEp-2 cells were treated with actinomycin D (4 p.g/ml) at 16 h post-infection and at 24 h after infection the total RNA was extracted using guanidinium thiocyanate (Chirgwin et al., 1979) . The poly(A) ÷ fraction of the total RNA was recovered using Hybond mAP affinity paper (Amersham).
Preparation ofcDNA clones. A library of RS virus cDNA clones was produced using a commercial kit (Amersham) based on the method of Gubler & Hoffman (1983) . The double-stranded cDNA was treated with EcoRI methylase prior to the addition of EcoRI linkers and EcoRI digestion. Linkered cDNA was ligated to EcoRl-cut pUCI8 and transferred into Escherichia coli JMI09 (Maniatis et al., 1982) . Clones carrying the RS virus F gene were identified by probing with a 32p. labelled F-specific oligonucleotide based on the sequence of .
DNA sequence analysis. Sequence analysis of the cloned F gene was by the dideoxynucleotide chain-terminating procedure (Sanger et al., 1977) using buffer gradient sequencing gels. The insert of one fulllength clone (pRSF1) was excised and subcloned into M13 mpl8 and mpl9 vectors (Yanisch-Perron et al., 1985) . Sequencing was achieved using a set of synthetic oligonucleotide primers which covered both strands. Computer analysis of the sequence data was performed using the Staden-Plus software (Amersham).
Oligonucleotide synthesis. Oligonucleotides were produced on a fully automated synthesizer using fl-eyanoethylphosphoramidite chemistry (Applied Biosystems 381A). Oligonucleotide primers for sequencing were used directly after deprotection and were not purified further.
Oligonucleotide probes. Oligonucleotides were radiolabelled using [),-32p]ATP and T4 polynucleotide kinase (BRL) as described by Maniatis et al. (1982) . Labelled oligonucleotides were purified using NENSORB columns (New England Nuclear) according to the manufacturer's instructions.
Peptide synthesis. Peptides were synthesized on solid polyethylene pins (Geysen et al., 1984) using a commercially available kit (Cambridge Research Biochemicals). Pentafluorophenyl (pfp) esters of fluorenylmethyloxycarbonyl (Fmoc)-L-amino acids with t-butyl derivatives as side chain-protecting groups: (Millipore) were used. For serine and threonine the pfp was replaced by oxybenzotriazine whereas for arginine there was a methoxytrimethylphenylsulpbonyl side chainprotecting group. Fmoc-protecting groups were removed by mild cleavage with 20 % (v/v) piperidine in dimethylformamide (DMF) and then activated by dissolving to 30 mM in DMF containing 30 mM-1-hydroxybenzotriazole as a catalyst. Amino acid coupling was done overnight at room temperature. Deprotection and coupling steps were repeated until the required peptide was synthesized. The N terminus of each peptide was acetylated by reaction with DMF:acetic anhydride : di-isopropylethylamine (50 : 5 : 1 v/v/v); final side chain deprotection was achieved using trifluoroacetic acid:phenol:ethanedithiol (95:2-5:2.5 v/v/v), neutralized by washing in dichloromethane:diisopropylethylamine (95 : 5 v/v). Successful syntheses were judged using negative and positive control pins which could be compared antigenically with control peptides supplied by the manufacturer.
Reactivity of antibodies to peptides. The immunoreactivity to human sera of the immobilized peptides was assayed using minor modifications to the manufacturer's instructions. The rods were blocked by immersion for 1 h in 2% (v/v) milk powder (Marvel, Cadbury) in phosphate-buffered saline (PBS) and then left to react overnight at 4 °C with antibody diluted in 2% Marvel in PBS containing 0-05% (v/v) Tween 20. Rods were washed four times in PBS-Tween 20 and the bound antibody was detected using affinity-purified goat anti-human IgG conjugated to horseradish peroxidase (Kirkegaard & Perry Laboratories). Pegs were then washed 10 times and bound enzyme was detected using 0.09 mM-2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) in 100 mM-Na2HPO4/80 mM-citric acid containing 0-3 ~tl of H2Oz/ml as substrate. Absorbances were read at 405 nm. All peptides were synthesized in duplicate and the assays were repeated to ensure reproducibility.
Human sera. Convalescent sera (AP, GW, TM and RD) were obtained from children recovering from proven RS virus infection. Neutralizing antibody levels were determined by endpoint plaque reduction assays. Heat-inactivated sera were serially diluted and incubated for 1 h at 37 °C with RS virus at 5 x 106 p.f.u./ml. The mixture was adsorbed onto HEp-2 cells and the syncytia were counted at 48 h. The 60% neutralizing dose (ND6o) was calculated by interpolation. Values for the sera were: AP, 1.25 x 104; GW, 7 x 104; TM, 1.56 x 105; RD, 6-25 x 103.
Prediction of B cell epitopes.
Computer prediction of potential epitopes was performed using a published program (Krchnfik et al., 1987) kindly provided on disk by Dr V. KrchnAk (L6civa Pharmaceuticals). The program predicts hydropathy, probability of /~-turn occurrence and preferred conformation for overlapping tetrapeptides.
Results

Sequence analysis of RS virus fusion protein
A cDNA library prepared from HEp-2 cells infected with the Edinburgh strain of RS virus was probed with F-specific oligonucleotides labelled with 3zp. One clone, pRSF1, was shown by restriction endonuclease mapping and sequence analysis to contain a full-length copy of the RS virus F gene. The cloned insert was released in whole or in part with a variety of restriction endonucleases for subcloning into mpl8 and mpl9 sequencing vectors. Sequence data were accumulated using a selection of cloned fragments and a set of synthetic oligonucleotide primers. Computer analysis of the nucleotide sequence revealed a single open reading frame of 1722 nucleotides encoding a protein of 574 amino acids. The amino acid sequence is compared with previously published sequences for F in Fig. 1 Elango et al., 1985; Baybutt & Pringle, 1987; Johnson & Collins, 1988) . It can be seen from Fig. 1 that the amino acid sequence in the Edinburgh strain, a subtype A virus, is remarkably consistent with the sequences of the Long, A2 and RSS-2 strains, although a degree of variation is seen mainly in the putative signal peptide region (residues 1 to 23). The subtype B 18537 strain has a somewhat greater divergence particularly in the region just before the putative proteolytic cleavage site (residues 131 to 136). However all strains showed extensive regions of sequence conservation, most notably in regions believed to be critical in the fusion process (residues 137 to 154), transmembrane region (residues 526 to 549) and potential glycosylation sites, although the A2 strain appears to lack one of the predicted glycosylation sites at position 120. Cysteine residues were conserved across all strains and a reported neutralizing epitope (Trudel et al., 1987) between residues 216 to 236 was conserved totally across the subtype A strains.
Epitope mapping
Computer prediction of secondary structure (Krchn/tk et al., 1987) suggested a number of regions of high potential to form fl-turns flanked by segments with a marked potential to form fl-sheets and a-helices (Table 1) . Trudel et al. (1987) showed that an RS virus-neutralizing MAb reacted with a proteolytic cleavage fragment of F probably in the region of Ser at position 215 (Ser 215) to Glu 236. In order to determine whether human sera with high neutralizing titres react to this or to other short linear epitopes, we have synthesized decameric peptides overlapping by five residues across F omitting only the signal peptide and the transmembrane anchor region.
The reactivities of two sera, GW and AP, to these peptides are shown in Fig. 2 ; the other two sera tested gave comparable results. Decameric peptides crossing the region Lys 470 to Ala 490 reacted strongly with all :~ Ph, Pt, Ps, the conformational potential of a-helix, fl-turn and flsheet respectively. § C, Preferred type of conformation; t, turn. sera tested (Fig. 2) 
Analysis of antibody binding site
To localize the epitope, overlapping hexameric peptides (Asn 476 to Ile 492) were synthesized and tested against sera GW and AP. Peptide FPSDEF (positions 483 to 488) was the most reactive towards both sera (Fig. 3) , with the overlapping tetrapeptides FPSD and PSDE giving high probabilities of immunogenic/~-turn occurrence (Table 2) . Krchn~_k et al. (1987) showed that when the probability of/?-turn occurrence was P > 1-5 x 10-4,
Hexameric peptides (Asn 476 to lie 492) as with the overlapping tetrapeptides 483 and 484, then 96~ of antipeptide antibodies reacted with the protein, compared with 46~ when the probability was P < 1-5 x 10 -4. The theoretical prediction of potential immunogenic determinants based on secondary structure was in close agreement with the experimentally determined reactivity of synthetic peptides. In order to establish the critical binding requirements, replacement nests were synthesized with each amino acid within the sequence FPSDEF (483 to 488) substituted with one of the remaining 19 commonly occurring L-amino acids. The data (Fig. 4) are presented with functionally equivalent amino acids adjacent to each other. The key finding was that amino acids Pro 484 and Glu 487 were critical components of the binding site and cannot be substituted. The remaining amino acids could be replaced with functionally equivalent amino acids without a marked loss of reactivity to those antibodies tested. The serine at position 3 appeared least critical permitting a wide range of replacements, some of which (Arg, Lys, Gin, Asn, Pro and Val) showed enhanced reactivity to antibody when compared to the parent peptide. Similarly, replacement of Phe with Met at position 1 increased antibody binding. These findings were confirmed in repeat experiments.
Discussion
The primary amino acid sequence of F of RS virus was deduced from a cDNA clone of the Edinburgh strain of the virus. The amino acid sequence was very similar to other published sequences, with homologies greater than 97~ for other subtype A strains and a somewhat lower homology (90~) with the subtype B strain. Many of the amino acid substitutions were to functionally related amino acids with the greatest variation occurring in the presumed signal peptide region of the protein: the signal sequences of the Edinburgh and the 18537 strains showed only 35~ identity. Conversely the presumed cleavage and fusion domain (residues 130 to 150) was totally conserved across all strains. Also the number and position of cysteine residues was identical in all strains indicating the importance of these residues to the overall structure and function of the mature protein.
Most antibodies produced against native proteins recognize conformational sites and, consequently, fail to bind peptides or proteolytic fragments with high affinity (Benjamin et al., 1984) . However some antibodies raised against viral antigens react with peptide homologues of the protein sequence, permitting the chemistry of such binding sites to be probed to the resolution of a single amino acid Getzoff et al., 1987) . Such studies are important when it can be shown that neutralizing antibodies react with sequential epitopes and that immunization with the peptide induces protective immunity. Examples reviewed by Steward & Howard (1987) include immunization with residues 131 to 160 of VPI from foot-and-mouth-disease virus, peptide 139 to 147 of the hepatitis B surface antigen, and peptides 735 to 752 and 503 to 532 of the human immunodeficiency virus surface glycoprotein. The studies of Trudel et al. (1987) demonstrated that a neutralizing MAb identified a peptide (Asn 216 to Glu 236) which blocked antibody action in both neutralizing and plaque reduction assays. In our study, using convalescent patient sera with high titres of neutralizing antibodies, we were unable to detect antibodies which bound either to hexameric Or decameric peptides spanning this region. There are important technical differences between our study using peptides synthesized on polyethylene pins and the work of Trudel et al. where purified peptides were blotted onto nitrocellulose. Following the protocols used by Geysen et al. (1984) , peptides were sonicated in the presence of 1 ~ SDS prior to reaction with the antibodies: binding of SDS could interfere with spontaneous folding of the peptide. Bosch et al. (1987) have shown that a neutralizing MAb to herpes simplex virus type 1 glycoprotein D no longer bound to peptides 9 to 21 and 8 to 30 after treatment with 0.1 ~ (w/v) SDS at 100 °C. The suggested explanation was that the shape held by the peptide was critical for MAb binding. Thus, although we can exclude the possibility that neutralizing antibodies generated in response to natural infection do not react with short linear epitopes within the antigenic region (Asn 216 to 140   120   100   80   60   40   20   0   I  I  I  r  I  I  I  I  I  I  I  I  I  I  I  I  I (a) Glu 236) described by Trudel et al. (1987) , there remains the possibility that short conformationally dependent neutralizing epitopes exist in this region. We have identified on the F1 subunit of F a short peptide FPSDEF (483 to 488) which has high potential to form a fl-turn and reacted strongly with the four human sera tested. Replacement studies where each amino acid in the sequence FPSDEF was substituted with the 19 common L-amino acids, identified two residues (Pro at position 2 and Glu at position 5) critical for antibody binding. The remaining amino acids could be substituted by structurally similar amino acids without loss of antigenicity. In particular, replacement of Ser at position 3 with several amino acids including Pro, Val, Asn and Gin enhanced the binding of natural human antibodies to the peptide. These data permit us to synthesize peptides in order to examine their ability to generate neutralizing antibodies and to assess their potential value in serological tests for RS virus infection. G.S. was supported by a Medical Research Council research studentship. The authors thank the Medical Research Council for a project grant.
